您搜索了: survival (丹麦语 - 英语)

survival probability
other (n=252)

survival time (months)
survival time (months)

sandsynlighed for overall survival
probability of overall survival

18 0parameter disease- free survival
parameter disease-free survival

1- års overall survival- frekvens
1-year overall survival rate

studiets primære endepunkt var overall survival.
the primary endpoint of the study was overall survival.

- antal patienter uden en hændelse recurrence- free survival
- no. patients with event - no. patients without event distant disease-free survival

kaplan-meier kurver for overall survival (itt population)
kaplan-meier curves for overall survival (itt population)

den primære effektparameter var samlet overlevelse (os, overall survival).
the primary efficacy outcome measure was overall survival (os).

det primære endepunkt var progressionsfri overlevelse (pfs, progression free survival).
the primary endpoint was progression free survival (pfs).

precision of epa seven-day fathead minnow larval survival and growth test;
precision of epa seven-day fathead minnow larval survival and growth test;

kaplan meier-kurver over overlevelse (os, overall survival) efter histologi
kaplan meier plots of overall survival by histology

kaplan meier-kurver for overlevelse (overall survival - os) efter histologi
kaplan meier plots of overall survival by histology

der blev ikke påvist signifikante forskelle i den samlede overlevelse (overall survival - os).
no significant differences were detected in overall survival (os).

der blev ikke påvist signifikante forskelle i den samlede overlevelse (overall survival -os) .middel -
no significant differences were detected in overall survival (os) .

for at støtte dem i disse formidlings­aktiviteter har kommissionen udgivet håndbogen "communicating science, a survival kit for scientists".
to support them in these public outreach activities, the commission has made available the handbook “communicating science, a survival kit for scientists”.

gennemsnitstiden for progressionsfri overlevelse (pfs, progression free survival) var 47, 3 uger (95% konfideninterval:
the median time of progression free survival (pfs) was 47.3 weeks (95% ci:

mosman, t. (1983) rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.
mosman, t. (1983) rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

overall survival (os): den samlede overlevelse varierede fra 29 % til 87 % med en opfølgningsperiode, der varierede fra 22 til 63 måneder.
overall survival (os): os ranged from 29% to 87% with a follow-up ranging from 22 up to 63 months.

612182430survival time (months) survival time (months)der blev ikke set nogen klinisk relevante forskelle i sikkerhedsprofilen af alimta inden for de histologiske undergrupper.
survival probability1.0 0.9 0.80.7 0.6 0.5 0.4 0.3 0.2 0.1 0.06large cell carcinoma12 18 24 survival time (months)acgc30survival time (months)there were no clinically relevant differences observed for the safety profile of alimta plus cisplatin within the histology subgroups.